Who is sponsoring NCT04295616?

NCT04295616 is sponsored by National Multiple Sclerosis Center.

What drugs are being tested in NCT04295616?

Interventions in NCT04295616: Intrapulmonary percussive ventilation (IPV), Active breathing training.

What condition does NCT04295616 study?

NCT04295616 studies Multiple Sclerosis.

Is NCT04295616 still recruiting?

NCT04295616 is currently terminated. Last updated 5 August 2020.

Last reviewed 2020-08-05 · How we verify

NCT04295616

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Additional Effect of Intrapulmonary Percussive Ventilation (IPV) on Respiration in People With Multiple Sclerosis (MS).

Terminated NA Last updated 5 August 2020

What this trial tests

NA trial testing Intrapulmonary percussive ventilation (IPV) in Multiple Sclerosis in 5 participants. Terminated before completion.

Timeline

13 January 2020

Primary endpoint
20 July 2020

20 July 2020

Quick facts

Lead sponsor	National Multiple Sclerosis Center
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	5
Start date	13 January 2020
Primary completion	20 July 2020
Estimated completion	20 July 2020
Sites	1 location across Belgium

Drugs / interventions tested

Intrapulmonary percussive ventilation (IPV)
Active breathing training

Conditions studied

Multiple Sclerosis — all drugs for Multiple Sclerosis →

Sponsor

National Multiple Sclerosis Center

Who can join

18 and older, any sex, with Multiple Sclerosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to investigate whether intrapulmonary percussive ventilation (IPV) in combination with active breathing exercises using the flow-based incentive spirometer (Inspirix) has a positive effect on the respiratory values in people with multiple sclerosis (MS).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Multiple Sclerosis

Currently open trials in the same condition.

NCT07507084 — The Effect of Internal- or External-Focused Exercise Training, Administered in Conjunction With a Cognitive Task, on Wal · NA · recruiting
NCT07524231 — Evaluation of the Effects of Laughter Yoga · NA · recruiting
NCT07489794 — URINARY INCONTINENCE AND PELVIC FLOOR MUSCLE ACTIVITY IN MULTIPLE SCLEROSIS · recruiting
NCT07236684 — Identification of Factors Related to UI in Patients With MS and EMG Assessment of PFM Activity · recruiting
NCT07500727 — Skeletal Muscle Aging and Responsiveness in Aged People With MS · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04295616 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by National Multiple Sclerosis Center
Last refreshed: 5 August 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04295616.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing